WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Wolters Kluwer offers free online access to support the fight against the Zika virus

Details
Development
09 March 2016
The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, is aiding clinicians in the battle against the rapidly spreading Zika virus through free online access to a number of its industry leading medical content and clinical decision support resources.
Read more ...

Predicting potential pharma side effects

Details
Development
08 March 2016
A computer program that can predict whether or not a given pharmaceutical will have worrying side effects has been developed by researchers in the USA. Jamiul Jahid and Jianhua Ruan of the Department of Computer Science, at the University of Texas at San Antonio, have developed the "in silico" testing system for drugs in the early stage of drug development.
Read more ...

How to prevent 10 million deaths a year

Details
Development
02 March 2016
Strategic investments to discover and develop new health tools, together with innovations in effectively delivering today's health tools and services, could avert 10 million deaths a year within just one generation, argue leading global health experts in a new PLOS Collection.
Read more ...

Linde Healthcare Continues to Support Innovation in Advanced Respiratory Care

Details
Development
29 February 2016
Linde Healthcare, a global business of The Linde Group, has announced the new beneficiaries of its REALfund initiative, a programme supporting ideas and projects with the potential to improve patient outcomes and health economics across the wide field of respiratory medicine.
Read more ...

Latest clinical information on Zika virus available at info centers on Elsevier Connect and The Lancet

Details
Development
24 February 2016
To help healthcare professionals, medical researchers and the public understand the ongoing outbreak of the Zika virus, Elsevier has created a Zika Virus Resource Center on Elsevier's public news and information website. In addition, The Lancet, one of Elsevier's top medical journals, has created a Zika virus resource centre on its website,
Read more ...

Are you working on a big bang company?

Details
Development
18 February 2016
MerckMerck, a leading science and technology company, announces the start of its equity-free accelerator program for digital health startups. Just as the big bang shaped the universe, Merck Accelerator is looking for startups with the potential to reshape entire industries and make people's lives richer.
Read more ...

Drug development crisis linked to bad technology choices, experts argue

Details
Development
15 February 2016
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say. They say drug discovery should focus on 'validity' - how well the results of experiments predict results in sick people. Instead, it has focused on methods that are easy to industrialize or methods that are academically fashionable.
Read more ...

More Pharma News ...

  1. LIGHTSABR - a cheap, portable drug-discovery system
  2. Clinical investigations of MRT are 'ethically permissible' if conditions met
  3. The effects of the Trans-Pacific Partnership on pharmaceutical innovation
  4. Global pharmaceutical industry calls on governments to work with them to beat the rising threat of drug resistance
  5. Stop spoon dosing
  6. Leading medical journals propose mandate on clinical data sharing
  7. New therapy aids bid to beat organ failure caused by pancreatitis
  • Start
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
  • End

Business & Industry

  • Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
  • New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta® (ofatumumab) had no evidence of disease activity (NEDA-3)
  • Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron
  • GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries
  • Novartis announces Nature Medicine publication of Zolgensma data demonstrating age-appropriate milestones when treating children with SMA presymptomatically

Research & Development

  • Researchers discover new leukemia-killing compounds
  • Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by researchers
  • Biomarkers found that could be drug targets against a deadly form of brain cancer
  • COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure
  • Novel drug combo activates natural killer cell immunity to destroy cancer cells
  • Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
  • A new technology offers treatment for HIV infection through a single injection

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Development
  4. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.